Tel: +44 (0) 1923 264338


Voluntary admissions to the PMCPA by companies undergoing audit

The definition and basis of self-regulation requires pharma companies to have in place processes to detect issues and correct/prevent them in an appropriate, robust and timely manner…

_However, is there an expectation by the PMCPA that such issues form part of a voluntary admission? What turns a deviation into a voluntary admission? _ There appears to be a trend with companies who are being audited by the PMCPA to make voluntary admissions to them during this time or afterwards. Examples of such companies are listed below: Sanofi Sanofi Genzyme Astellas Sunovion (not yet published)

Understandably, during audit, companies that are under intense scrutiny look more closely and broadly at their material and activities. You might argue that they should have been doing this all along…** An effective compliance programme aims to identify and manage risk on a continuous basis, to improve adherence to business requirements.** The question of whether to submit a voluntary admission or not, is left to the discretion of individual companies.

Ros Henley


Ros Henley

More news

Feedback on the ABPI Code

Content of the Code, Compliance Network Meetings & PMCPA Processes

Read article

The ABPI want to hear from you about the Code!

ABPI launch a research survey on the ABPI Code

Read article
View all